Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

From yesterday:
“After completing our Phase 1 Kevetrin study, we were invited by one of the world’s largest pharmaceutical companies to meet at their world headquarters and discuss our results,” said Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals."

Actual Study Completion Date : February 2016
https://clinicaltrials.gov/ct2/show/NCT01664000?term=cellceutix&rank=5


I think the point may be that there was no mention in the release of the fact that the meeting in question occurred over two and a half years ago. You're right. It is pretty amazing.